Evidence map›Paper›PMID 29795531›Full record

ArticleInternational journal of impotence research2018

Patient's choice of health information and treatment modality for Peyronie's disease: a long-term assessment.

Raevti Bole, Matthew Ziegelmann, Ross Avant, Brian Montgomery, Tobias Kohler, Landon Trost

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of impotence research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Raevti BoleDepartment of Urology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0001-5943-0185
Matthew ZiegelmannDepartment of Urology, Mayo Clinic, Rochester, MN, USA.
Ross AvantDepartment of Urology, Mayo Clinic, Rochester, MN, USA.
Brian MontgomeryDepartment of Urology, Mayo Clinic, Rochester, MN, USA.
Tobias KohlerDepartment of Urology, Mayo Clinic, Rochester, MN, USA.
Landon TrostDepartment of Urology, Mayo Clinic, Rochester, MN, USA. Trost.Landon@mayo.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite various Peyronie's disease (PD) treatment options, the literature is sparse regarding patient preference for available therapies. Our data explore resource and treatment choices made by PD men following diagnosis. A survey was mailed to 719 randomly selected PD men evaluated at our institution from 1990-2012. Questions included evaluation of treatments and preferred information resources. Results were summarized as a descriptive report with statistical analyses performed as indicated. A total of 162 men (median age 65) responded with median PD duration of 9.2 years. Information sources included medical websites (38.9%), physician (35.8%), and books (<1%). Overall, patients felt 72.5% (SD = 40) of physicians had a good understanding of PD. About 53.1% of men had tried at least one therapy with 37.2% trying two or more. In comparing therapies, most surgical patients reported improvement at 82.8%. Among a cohort of PD men responding to a mailed survey, medical websites were the most widely used source of information. Almost half of the patients chose not to pursue any form of therapy, while the remaining majority elected for non-operative intervention. These results suggest a need for greater patient and provider education on PD management.

Indexed as

Patient Education as TopicAgedHumansInformation ServicesInternetMaleMiddle AgedPatient PreferencePenile IndurationPhysician's RoleSurveys and QuestionnairesTreatment Outcome

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.